Pharmaceutical

CC-95775 by Bristol-Myers Squibb for Solid Tumor: Likel...

Jul 7, 2023

CC-95775 is under clinical development by Bristol-Myers Squibb and currently in ...

MesoCancerVac by Amphera for Metastatic Pancreatic Canc...

Jul 7, 2023

MesoCancerVac is under clinical development by Amphera and currently in Phase I ...

AC-0676 by Accutar Biotechnology for Follicular Lymphom...

Jul 7, 2023

AC-0676 is under clinical development by Accutar Biotechnology and currently in ...

Selinexor by Karyopharm Therapeutics for Osteosarcoma: ...

Jul 7, 2023

Selinexor is under clinical development by Karyopharm Therapeutics and currently...

ORIN-1001 by Shanghai Fosun Pharmaceutical (Group) for ...

Jul 7, 2023

ORIN-1001 is under clinical development by Shanghai Fosun Pharmaceutical (Group)...

CJ-15314 by HK inno.N for Atopic Dermatitis (Atopic Ecz...

Jul 7, 2023

CJ-15314 is under clinical development by HK inno.N and currently in Phase I for...

AMG-305 by Amgen for Breast Cancer: Likelihood of Approval

Jul 7, 2023

AMG-305 is under clinical development by Amgen and currently in Phase I for Brea...

Opinion: Listen: Is the medical system ready for Alzheimer’s drugs that work?

Opinion: Listen: Is the medical system ready for Alzhei...

Jul 6, 2023

Leqembi is a game-changer for Alzheimer's. But the health care system needs to c...

Opinion: Sen. Bill Cassidy: Smart, practical ways to lower drug prices

Opinion: Sen. Bill Cassidy: Smart, practical ways to lo...

Jul 6, 2023

The physician turned senator on how to balance the need to lower drug prices whi...

STAT+: Novo Nordisk bought prescribers over 450,000 meals and snacks to promote drugs like Ozempic

STAT+: Novo Nordisk bought prescribers over 450,000 mea...

Jul 6, 2023

Novo Nordisk bought 457,222 meals to educate doctors about its drugs like Ozempi...

STAT+: FDA approves first Alzheimer’s therapy shown to clearly slow cognitive decline

STAT+: FDA approves first Alzheimer’s therapy shown to ...

Jul 6, 2023

The FDA has granted full approval to the first therapy for Alzheimer’s disease c...

STAT+: Generic group sues Minnesota over a drug pricing transparency law it calls an ‘unconstitutional overreach’

STAT+: Generic group sues Minnesota over a drug pricing...

Jul 6, 2023

The generic trade group argued the “draconian regulations” come at a time when t...

Why depression after traumatic brain injury is distinct — and less likely to respond to standard treatment

Why depression after traumatic brain injury is distinct...

Jul 6, 2023

Depression after traumatic brain injury is distinct, a new study finds, and ther...

STAT+: Pharmalittle: Next big hope for Alzheimer’s might not help most Black patients; drugmakers ask Supreme Court to toss terrorism-support ruling

STAT+: Pharmalittle: Next big hope for Alzheimer’s migh...

Jul 6, 2023

Critics say any positive impact from the Alzheimer's drug Leqembi will not benef...

Drinking water from nearly half of U.S. faucets likely contains “forever chemicals”: Study

Drinking water from nearly half of U.S. faucets likely ...

Jul 6, 2023

The study “can be used to evaluate risk of exposure and inform decisions about w...

STAT’s Inaugural Diversity Report and Commitment to a Workplace of Diversity and Inclusion

STAT’s Inaugural Diversity Report and Commitment to a W...

Jul 6, 2023

The STAT Diversity and Inclusion Committee is proud to present STAT's inaugural ...